AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 83 filers reported holding AVIDITY BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,085,027 | -42.5% | 170,067 | 0.0% | 0.01% | -42.9% |
| Q2 2023 | $1,886,043 | -21.5% | 170,067 | 0.0% | 0.01% | -17.6% |
| Q1 2023 | $2,402,806 | -48.7% | 170,067 | -19.4% | 0.02% | -46.9% |
| Q4 2022 | $4,683,357 | +35.9% | 211,067 | 0.0% | 0.03% | +33.3% |
| Q3 2022 | $3,447,000 | +12.4% | 211,067 | 0.0% | 0.02% | -4.0% |
| Q2 2022 | $3,067,000 | +3.8% | 211,067 | +31.9% | 0.02% | +25.0% |
| Q1 2022 | $2,955,000 | -22.3% | 159,988 | 0.0% | 0.02% | -16.7% |
| Q4 2021 | $3,803,000 | -2.6% | 159,988 | +0.9% | 0.02% | -11.1% |
| Q3 2021 | $3,906,000 | -1.2% | 158,588 | -0.9% | 0.03% | 0.0% |
| Q2 2021 | $3,953,000 | +727.0% | 159,988 | +720.6% | 0.03% | +575.0% |
| Q1 2021 | $478,000 | -4.0% | 19,497 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $498,000 | -11.5% | 19,497 | -2.5% | 0.00% | -20.0% |
| Q3 2020 | $563,000 | -0.4% | 20,000 | 0.0% | 0.01% | -16.7% |
| Q2 2020 | $565,000 | – | 20,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,571,160 | $40,096,000 | 20.10% |
| Aaron Wealth Advisors LLC | 524,239 | $13,378,000 | 4.90% |
| Octagon Capital Advisors LP | 430,041 | $10,975,000 | 3.80% |
| EcoR1 Capital, LLC | 2,103,950 | $53,693,000 | 2.89% |
| RTW INVESTMENTS, LP | 3,995,000 | $101,952,000 | 1.71% |
| ACUTA CAPITAL PARTNERS, LLC | 246,200 | $6,283,000 | 1.71% |
| Cormorant Asset Management, LP | 2,464,547 | $62,895,000 | 1.50% |
| Logos Global Management LP | 671,454 | $17,136,000 | 1.47% |
| Boxer Capital, LLC | 1,121,327 | $28,616,000 | 0.92% |
| HighVista Strategies LLC | 26,665 | $680,000 | 0.43% |